The cell line was grown and maintained by culturing with feeder cells (SL10, Reprocell Inc.) at 37 C in 5% CO 2 in a humidified atmosphere, using Primate ES cell medium (Reprocell Inc.), supplemented with bFGF (Fujifilm Wako Pure Chemical Corporation)
Cagrilintide has similar GI tolerability, with one important difference: it causes more severe sickness at the start of treatment, which is thought to be because it strongly slows down stomach motility
Most of the risks of these compounds stem from the absence of clinical trials and reliable data in humans, making it impossible to establish appropriate dosing, long-term safety, or adverse event profiles
Int J Biol Macromol 163:603617
What patients notice first depends on their individual baseline
Common Administration Methods Peptide therapy usually involves simple, self-administered injections